These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Organic solvents and chronic glomerulonephritis: a cross-sectional study with negative findings for aliphatic and alicyclic C5-C7 hydrocarbons. Mutti A, Lucertini S, Falzoi M, Cavatorta A, Franchini I. J Appl Toxicol; 1981 Aug; 1(4):224-6. PubMed ID: 7184941 [Abstract] [Full Text] [Related]
29. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G. Kidney Int; 2000 Oct; 58(4):1732-41. PubMed ID: 11012907 [Abstract] [Full Text] [Related]
30. Progression of renal failure in chronic primary glomerular diseases. Gonzalo A, Gallego A, Rivera M, Gallego N, Ortuño J. Nephron; 1994 Oct; 68(1):32-7. PubMed ID: 7991038 [Abstract] [Full Text] [Related]
36. [Glomerulonephritis and vasculitis as causes of arterial hypertension]. Eicken S, Gugger M, Marti HP. Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360 [Abstract] [Full Text] [Related]
37. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy. Branten AJ, Klasen IS, Wetzels JF. Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841 [Abstract] [Full Text] [Related]
38. Prognostic factors in mesangioproliferative glomerulonephritis. Vikse BE, Bostad L, Aasarød K, Lysebo DE, Iversen BM. Nephrol Dial Transplant; 2002 Sep; 17(9):1603-13. PubMed ID: 12198211 [Abstract] [Full Text] [Related]
39. [Systemic arterial hypertension in primary chronic glomerulonephritis: prevalence and its influence on the renal prognosis]. Quirós PL, Ceballos M, Remón C, Hernández Romero MC, Benavides B, Pérez Pérez-Ruilópez MA, Lozano A, Aznar E, Rivero M, Fernández Ruiz E. Nefrologia; 2005 Sep; 25(3):250-7. PubMed ID: 16053006 [Abstract] [Full Text] [Related]